ADAP Stock Forecast & Price Target
ADAP Stock
Price Forecast
The average stock forecast for
Adaptimmune Therapeutics PLC (ADAP) in the next 12 months is 0.47 USD. This price target corresponds to an upside
of
754.64%. The range of stock forecasts for ADAP is 0.46 - 0.48 USD.
Based on the ratings of 6 analysts, the consensus recommendation for ADAP is
HOLD.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
0.46 |
0.47 |
0.47 |
0.48 |
| Upside |
746.27% |
754.64% |
754.64% |
779.78% |
Recommendation Trends
The latest consensus rating for ADAP is "HOLD". This is the average
recommendation of 6 analysts: 2 strong sell,
2 sell, 2 hold, 0 buy, 0 strong buy. In the previous period, 6 analysts also majorly recommmended
"SELL" for ADAP.
ADAP Financial Stock
Forecast
Revenue This Year
from 178.03M
Revenue Next Year
from 26.52M